New hope for kids with rare genetic disease: experimental enzyme therapy trial opens

NCT ID NCT06328608

Summary

This study is testing an enzyme replacement therapy called PRX-102 in children and adolescents aged 2 to 17 who have Fabry disease, a rare genetic disorder. The main goals are to find the safest and most effective dose for young patients and to see how well the treatment works at managing symptoms like pain, heart problems, and kidney issues. About 22 participants will receive the drug through an IV every two weeks, and researchers will monitor their health closely over time.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FABRY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Centre Hospitalier Universitaire (CHU) de Bordeaux - Groupe Hospitalier Pellegrin

    RECRUITING

    Bordeaux, 33076, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Cincinnati Children's Hospital Medical Center

    NOT_YET_RECRUITING

    Cincinnati, Ohio, 45229, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Emory Genetics Clinical Trials Center

    RECRUITING

    Atlanta, Georgia, 30322, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Great Ormond Street Hospital for Children NHS Foundation Trust

    NOT_YET_RECRUITING

    London, United Kingdom

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Haukeland Universitetssjukehus

    RECRUITING

    Bergen, 5021, Norway

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Hopital Arnaud de Villeneuve

    RECRUITING

    Montpellier, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Hospital Clinico Universitario De Santiago De Compostela

    RECRUITING

    Santiago de Compostela, Spain

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Lysosomal and Rare Disorders Research and Treatment Center Inc

    NOT_YET_RECRUITING

    Fairfax, Virginia, 22030, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Phoenix Children's

    RECRUITING

    Phoenix, Arizona, 85016, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • UK für Kinder- und Jugendheilkunde der PMU Salzburg

    RECRUITING

    Salzburg, Austria

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University of Iowa

    RECRUITING

    Iowa City, Iowa, 52242, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University of Utah

    RECRUITING

    Salt Lake City, Utah, 84108, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.